Anavex Life Sciences Corp (AVXL)
Cash & Short-Term Investments
$118.33M
Quarterly · Period ending: · USD
AVXL Cash & Short-Term Investments
Latest reported$118.33Mperiod ending
Latest reported$118.33Mperiod ending
AVXL Quarterly Cash & Short-Term Investments ($977.00 → $118.33M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
AVXL cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 118,326,000 | |
| 127,422,000 | |
| 131,749,000 | |
| 102,577,000 | |
| 101,164,000 | |
| 115,771,000 | |
| 120,775,000 | |
| 132,187,000 | |
| 138,756,000 | |
| 139,386,000 | |
| 143,765,000 | |
| 151,024,000 | |
| 154,817,164 | |
| 153,466,962 | |
| 143,621,848 | |
| 149,157,861 | |
| 153,199,352 | |
| 153,342,556 | |
| 151,146,355 | |
| 152,107,745 | |
| 157,560,045 | |
| 75,859,339 | |
| 47,357,599 | |
| 29,249,018 | |
| 27,619,145 | |
| 26,563,071 | |
| 27,458,423 | |
| 22,185,630 | |
| 21,249,206 | |
| 19,457,845 | |
| 20,715,169 | |
| 22,930,638 | |
| 25,827,592 | |
| 25,656,584 | |
| 28,048,644 | |
| 27,440,257 | |
| 24,793,424 | |
| 23,351,567 | |
| 21,161,460 | |
| 9,186,814 | |
| 9,727,040 | |
| 11,950,847 | |
| 13,853,405 | |
| 15,290,976 | |
| 8,025,039 | |
| 6,310,643 | |
| 6,980,924 | |
| 7,262,138 | |
| 8,179,681 | |
| 9,193,558 | |
| 95,927 | |
| 345,074 | |
| 1,645 | |
| 487 | |
| 79,789 | |
| 11,362 | |
| 18,195 | |
| 178,647 | |
| 9,079 | |
| 134,702 | |
| 1,222,654 | |
| 3,641 | |
| 423,783 | |
| 264,669 | |
| 1,458,439 | |
| 144,510 | |
| 21,034 | |
| 350,994 | |
| 742,577 | |
| 78,729 | |
| 614 | |
| 6,357 | |
| 5,799 | |
| 9,188 | |
| 48,582 | |
| 25 | |
| 118 | |
| 15,022 | |
| 4,516 | |
| 12,275 | |
| 19,881 | |
| 130 | |
| 130 | |
| 977 |